HHS said Moderna will develop and assess an mRNA vaccine against H7N9 avian influenza in a phase 3 clinical trial. The company will also design up to four other novel pandemic flu vaccines and do the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback